Microbot Medical (MBOT) Earnings Analysis

Microbot Medical (MBOT) next reports earnings on 2026-08-11, consensus EPS -0.08 USD. Last quarter (2026-03-26) it beat with EPS -0.04 USD vs -0.06 USD est (+33.3%). It has beaten estimates in 3/4 recent quarters (75%). Trailing P/E -6.40.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does MBOT next report earnings?

Next earnings date2026-08-11
Consensus EPS estimate-0.08 USD
Revenue estimate0.00B

MBOT earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-26-0.04 USD-0.06 USD+33.3%Beat
2025-11-12-0.07 USD-0.06 USD-16.7%Miss
2025-05-14-0.08 USD-0.13 USD+38.5%Beat
2024-08-14-0.17 USD-0.17 USD0%Beat

Beat rate: 3/4 (75%) over reported quarters with consensus data.

MBOT valuation and analyst view

Trailing P/E-6.40
Trailing EPS-0.21162 USD
Price / book1.60
Dividend yield0.00%
Market cap0.08B
Analyst consensusBuy (2 buy / 1 hold / 0 sell)
Avg price target4 USD

Related research pages

Frequently asked questions

When is Microbot Medical (MBOT)'s next earnings date?

Microbot Medical is next scheduled to report on 2026-08-11, with a consensus EPS estimate of -0.08 USD and revenue estimate of 0.00B.

Did MBOT beat earnings last quarter?

In its 2026-03-26 report, MBOT posted EPS of -0.04 USD versus a -0.06 USD estimate — a beat of 33.3%.

What is MBOT's earnings track record?

Over the last 4 reported quarters with consensus data, MBOT beat estimates 3 times (75%).

What is MBOT's current P/E ratio and EPS?

MBOT trades at a trailing P/E of -6.40 on trailing EPS of -0.2116202193143088 USD.

What do analysts rate MBOT?

Analyst consensus is "Buy" across 3 ratings (0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 4 USD.